Breaking News

Charles River, PathoQuest Expand Strategic Biologics Pact

Charles River will provide clients access to PathoQuest’s NGS-based testing solutions

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Laboratories and PathoQuest have expanded their strategic partnership agreement to provide next-generation sequencing (NGS) services to the biologics industry. As part of the expanded partnership, Charles River intends to make a direct investment in PathoQuest.   Since 2016, Charles River has provided clients access to PathoQuest’s NGS solution, which combines a sample preparation method, equipment, and an exclusive curated pathogen database with a comprehensive BioIT analysis pi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters